Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens
- 31 August 1991
- Vol. 9 (8) , 545-548
- https://doi.org/10.1016/0264-410x(91)90240-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriageVaccine, 1990
- Hepatitis B: the diseaseVaccine, 1990
- Randomized Dose Range Study of a Recombinant Hepatitis B Vaccine Produced in Mammalian Cells and Containing the S and PreS2 SequencesThe Journal of Infectious Diseases, 1989
- Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface proteinJournal of Medical Virology, 1989
- Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothersHepatology, 1988
- Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypesMolecular Immunology, 1987
- Perinatal transmission of hepatitis B virus in highincidence countriesJournal of Virological Methods, 1987
- Enhanced Immunogenicity of the Pre-S Region of Hepatitis B Surface AntigenScience, 1985
- IMMUNE RESPONSE IN NEONATES TO HEPATITIS B VACCINEThe Lancet, 1982
- Vertical Transmission of Hepatitis B Antigen in TaiwanNew England Journal of Medicine, 1975